Quick Takeaways
- Nantahala Capital Management, LLC filed SCHEDULE 13G for RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share (RAPT).
- Disclosed ownership: 5.8%.
- Date of event: 30 Jun 2025.
Nantahala Capital Management, LLC - 30 Jun 2025 SCHEDULE 13G Report for RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share (RAPT)
- Filing Manager
- Nantahala Capital Management, LLC
- Reporting Manager
- Nantahala Capital Management, LLC
- Symbol
- RAPT
- Shares outstanding
- 16,549,791 shares
- Disclosed Ownership
- 951,613 shares
- Ownership
- 5.8%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Aug 2025, 16:34:01 UTC
- Date of event
- 30 Jun 2025
- Next filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Nantahala Capital Management, LLC disclosed 5.8% ownership in RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share (RAPT) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 16:34.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 5.8% | 951,613 | 0 | 951,613 | /s/ Taki Vasilakis | Taki Vasilakis / Chief Compliance Officer | |
| Wilmot B. Harkey | 5.8% | 951,613 | 0 | 951,613 | /s/ Wilmot B. Harkey | Wilmot B. Harkey | |
| Daniel Mack | 5.8% | 951,613 | 0 | 951,613 | /s/ Daniel Mack | Daniel Mack |